Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model

Journal of the Acoustical Society of America

Volumn 128, Issue 3, 2010, Pages 1163-1174

  Dille, Marilyn F ^a   McMillan, Garnett P ^a   Reavis, Kelly M ^b   Jacobs, Peter ^a   Fausti, Stephen A ^a   Konrad Martin, Dawn ^a  

^a NATIONAL CENTER FOR REHABILITATIVE AUDITORY RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS-PLATIN; DISTORTION PRODUCT OTOACOUSTIC EMISSIONS; HEARING LOSS; HIGH FREQUENCY; LEVEL SHIFT; OBJECTIVE METHODS; OTOTOXICITY; PARTIAL LEAST SQUARES; PRE-TREATMENT; RECEIVER OPERATING CHARACTERISTIC ANALYSIS; RISK FACTORS;

ACOUSTIC EMISSIONS; AUDITION; PLATINUM COMPOUNDS;

RISK ASSESSMENT;

ANTINEOPLASTIC AGENT; CISPLATIN;

AGED; ARTICLE; AUDITORY STIMULATION; AUDITORY THRESHOLD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; HEARING LOSS; HUMAN; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PSYCHOPHYSICS; PURE TONE AUDIOMETRY; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS OTOACOUSTIC EMISSION; VETERAN;

ACOUSTIC STIMULATION; AGED; ANTINEOPLASTIC AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HEARING LOSS; HUMANS; LEAST-SQUARES ANALYSIS; MIDDLE AGED; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PREDICTIVE VALUE OF TESTS; PSYCHOACOUSTICS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; VETERANS;

EID: 77956404890     PISSN: 00014966     EISSN: None     Source Type: Journal    
DOI: 10.1121/1.3473693     Document Type: Article

References (44)

1. Alam, S., Ikeda, K., Oshima, T., Suzuki, M., Kawase, T., Kikuchi, T., and Takasaka, T. (2000). " Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea.," Hear. Res. HERED3 0378-5955 141, 28-38. 10.1016/S0378-5955(99)00211-7 (Pubitemid 30125313)
2. Amalraj, S., Starkweather, C., Nguyen, C., and Naeim, A. (2009). " Health literacy, communication, and treatment decision-making in older cancer patients.," Oncology ONCOBS 0030-2414 23, 369-375.
3. Arnold, D., Lonsbury-Martin, B., and Martin, G. (1999). " High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions.," Arch. Otolaryngol. Head Neck Surg. AONSEJ 0886-4470 125, 215-222.
4. ASHA (1994). " Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy.," American Speech-Language-Hearing Association, www.ashaorg/docs/html/GL1994-00003.html, pp. 11-19.
5. Barker, M., and Rayens, W. (2003). " Partial least squares for discrimination.," J. Chemom. JOCHEU 0886-9383 17, 166-173. 10.1002/cem.785
6. Beattie, R., Kenworthy, O., and Luna, C. (2003). " Immediate and short-term reliability of distortion-product otoacoustic emissions.," Int. J. Audiol. ZZZZZZ 1499-2027 42, 348-354. 10.3109/14992020309101328
7. Carhart, R., and Jerger, J. (1959). " Preferred method for clinical determination of pure-tone thresholds.," J. Speech Hear Disord. ZZZZZZ 0022-4677 24, 330-345.
8. Dalton, D., Cruickshanks, K., Klein, B., Klein, R., Wiley, T., and Nondahl, D. (2003). " The impact of hearing loss on quality of life in older adults.," Gerontologist GRNTA3 0016-9013 43, 661-668.
9. Deeter, R., Abel, R., Calandruccio, L., and Dhar, S. (2009). " Contralateral acoustic stimulation alters the magnitude and phase of distortion product otoacoustic emissions.," J. Acoust. Soc. Am. JASMAN 0001-4966 126, 2413-2424. 10.1121/1.3224716
10. Dorn, P., Piskorski, P., Gorga, M., Neely, S., and Keefe, D. (1999). " Predicting audiometric status from distortion product otoacoustic emissions using multivariate analysis.," Ear Hear. EAHEDS 0196-0202 20, 149-163. 10.1097/00003446-199904000-00006
11. Durrant, J., Palmer, C., and Lunner, T. (2005). " Analysis of counted behaviors in a single-subject design: Modeling of hearing-aid intervention in hearing-aid patients with Alzheimer's disease.," Int. J. Audiol. ZZZZZZ 1499-2027 44, 31-38. 10.1080/14992020400022637 (Pubitemid 40364853)
12. Fausti, S., Frey, R., Erickson, D., Rappaport, B., Cleary, E., and Brummert, R. (1979). " A system for evaluating auditory function from 8,000-20,000 Hz.," J. Acoust. Soc. Am. JASMAN 0001-4966 66, 1713-1718. 10.1121/1.383643
13. Fausti, S., Frey, R., Henry, J., Olson, D., and Schaffer, H. (1992). " Early detection of ototoxicity using high-frequency, tone-burst-evoked auditory brainstem responses.," J. Am. Acad. Audiol ZZZZZZ 1050-0545 3, 397-404.
14. Fausti, S., Rappaport, B., Frey, R., Henry, J., Phillips, D., Mitchell, C., and Olson, D. (1991). " Reliability of evoked responses to high-frequency (8-14 kHz) tone bursts.," J. Am. Acad. Audiol ZZZZZZ 1050-0545 2, 105-114.
15. Fischel-Ghodsian, N., Prezant, T., Bu, X., and Oztas, S. (1993). " Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity.," Am. J. Otolaryngol. AJOTDP 0196-0709 14, 399-403. 10.1016/0196-0709(93)90113-L (Pubitemid 23337068)
16. Fitzmaurice, G., Laird, N., and Ware, J. (2004). Applied Longitudinal Analysis (Wiley, Hoboken, NJ), pp. 291-321.
17. Forge, A., and Schacht, J. (2000). " Aminoglycoside antibiotics.," Audiol. Neuro-Otol. ANEOFO 1420-3030 5, 3-22. 10.1159/000013861
18. Franklin, D., McCoy, M., Martin, G., and Lonsbury-Martin, B. (1992). " Test/retest reliability of distortion-product and transiently evoked otoacoustic emissions.," Ear Hear. EAHEDS 0196-0202 13, 417-429. 10.1097/00003446-199212000-00008
19. Gorga, M., Neely, S., and Dorn, P. (1999). " Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards.," Ear Hear. EAHEDS 0196-0202 20, 345-362. 10.1097/00003446-199908000-00007 (Pubitemid 29382374)
20. Gorga, M., Neely, S., Ohlrich, B., Redner, J., and Peters, J. (1997). " From laboratory to clinic: A large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss.," Ear Hear. EAHEDS 0196-0202 18, 440-455. 10.1097/00003446-199712000- 00003 (Pubitemid 28012101)
21. Gorga, M., Stover, L., Neely, S., and Montoya, D. (1996). " The use of cumulative distributions to determine critical values and levels of confidence for clinical distortion product otoacoustic emission measurements.," J. Acoust. Soc. Am. JASMAN 0001-4966 100, 968-977. 10.1121/1.416208
22. Hanley, J., and McNeil, B. (1982). " The meaning and use of the area under a receiver operating characteristic (ROC) curve.," Radiology RADLAX 0033-8419 143, 29-36.
23. Harding, G., and Bohne, B. (2004). " Temporary DPOAE level shifts, ABR threshold shifts and histopathological damage following below-critical-level noise exposure.," Hear. Res. HERED3 0378-5955 196, 94-108. 10.1016/j.heares.2004.03.011 (Pubitemid 39298900)
24. Hastie, T., Tibshirani, R., and Friedman, J. (2009). The Elements of Statistical Learning: Data Mining, Inference and Prediction (Springer, New York), pp. 241-245.
25. Hodges, A., and Lonsbury-Martin, B. (1998). Hearing Management (Singular, San Diego), pp. 269-290.
26. Howard, M., Stagner, B., Lonsbury-Martin, B., and Martin, G. (2002). " Effects of reversible noise exposure on the suppression tuning of rabbit distortion-product otoacoustic emissions.," J. Acoust. Soc. Am. JASMAN 0001-4966 111, 285-296. 10.1121/1.1419094 (Pubitemid 34093323)
27. Knight, K., Kraemer, D., Winter, C., and Neuwelt, E. (2007). " Early changes in auditory function as a result of platinum chemotherapy: Use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.," J. Clin. Oncol. JCONDN 0732-183X 25, 1190-1195. 10.1200/JCO.2006.07.9723 (Pubitemid 46640564)
28. Kochkin, S., and Rogin, C. (2000). " Quantifying the obvious: The impact of hearing instruments on the quality of life.," Hear. Rev. ZZZZZZ 1074-5734 7, 6-34.
29. Laurell, G., Viberg, A., Teixeira, M., Sterkers, O., and Ferrary, E. (2000). " Blood-perilymph barrier and ototoxicity: An in vivo study in the rat.," Acta Oto-Laryngol. AOLAAJ 0001-6489 120, 796-803. 10.1080/000164800750061624 (Pubitemid 32511248)
30. Martin, G., Stagner, B., Fahey, P., and Lonsbury-Martin, B. (2009). " Steep and shallow phase gradient distortion product otoacoustic emissions arising basal to the primary tones.," J. Acoust. Soc. Am. JASMAN 0001-4966 125, EL85-EL92. 10.1121/1.3073734
31. Mauermann, M., and Kollmeier, B. (2004). " Distortion product otoacoustic emissions (DPOAE) input/output functions and the influence of the second DPOAE source.," J. Acoust. Soc. Am. JASMAN 0001-4966 116, 2199-2212. 10.1121/1.1791719 (Pubitemid 39391623)
32. Molinaro, A., Simon, R., and Pfeiffer, R. (2005). " Prediction error estimation: A comparison of resampling methods.," Bioinformatics BOINFP 1367-4803 21, 3301-3307. 10.1093/bioinformatics/bti499 (Pubitemid 41418445)
33. Mukherjea, D., Whitworth, C., Nandish, S., Dunaway, G., Rybak, L., and Ramkumar, V. (2006). " Expression of the kidney infury molecule 1 in the rat cochlea and induction by cisplatin.," Neuroscience NRSCDN 0306-4522 139, 733-740. 10.1016/j.neuroscience.2005.12.044
34. Neely, S., and Liu, Z. (1994). EMAV: Otoacoustic Emission Averager (Boys Town National Research Hospital, Omaha, NE).
35. Obuchowski, N. (1997). " Nonparametric analysis of clustered ROC curve data.," Biometrics BIOMB6 0006-341X 53, 567-578. 10.2307/2533958 (Pubitemid 27262219)
36. Radmacher, M., McShane, L., and Simon, R. (2002). " A paradigm for class prediction using gene expression profiles.," J. Comput. Biol. JCOBEM 1066-5277 9, 505-511. 10.1089/106652702760138592 (Pubitemid 34920572)
37. Reavis, K., McMillan, G., Austin, D., Fausti, S., and Konrad-Martin, D. (2010). " Distortion-product otoacoustic emission test performance for ototoxicity monitoring.," Ear Hear. EAHEDS 0196-0202 In press.
38. Reavis, K. M., Phillips, D. S., Fausti, S. J., Gordon, J. S., Helt, W. J., Willington, D., Bratt, G. W., and Konrad-Martin, D. (2008). " Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.," Ear Hear. EAHEDS 0196-0202 29, 875-893. 10.1097/AUD.0b013e318181ad99
39. Ress, B. D., Sridhar, K. S., Balkany, T. J., Waxman, G. M., Stagner, B. B., and Lonsbury-Martin, B. L. (1999). " Effects of cis-platin chemotherapy on otoacoustic emissions: The development of an objective screening protocol.," Otolaryngol.-Head Neck Surg. OHNSDL 0194-5998 121, 693-701. 10.1053/hn.1999.v121.a101567
40. Roede, J., Harris, F., Probst, R., and Xu, L. (1993). " Repeatability of distortion product otoacoustic emissions in normally hearing humans.," Audiology AUDLAK 0020-6091 32, 273-281. 10.3109/00206099309072943
41. Shera, C., and Guinan, J. (1999). " Evoked otoacoustic emissions arise by two fundamentally different mechanisms: A taxonomy for mammalian OAEs.," J. Acoust. Soc. Am. JASMAN 0001-4966 105, 782-798. 10.1121/1.426948 (Pubitemid 29061312)
42. Simon, R. (2005a). " Roadmap for developing and validating therapeutically relevant genomic classifiers.," J. Clin. Oncol. JCONDN 0732-183X 23, 7332-7341. 10.1200/JCO.2005.02.8712 (Pubitemid 46202346)
43. Stavroulaki, P., Vossinakis, I., Dinopoulou, D., Doudounakis, S., Adamopoulos, G., and Apostolopoulos, N. (2002). " Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis.," Arch. Otolaryngol. Head Neck Surg. AONSEJ 0886-4470 128, 150-155.
44. Sutton, L. A., Lonsbury-Martin, B. L., Martin, G. K., and Whitehead, M. L. (1994). Sensitivity of distortion-product otoacoustic emissions in humans to tonal over-exposure: Time course of recovery and effects of lowering L2.," Hear. Res. HERED3 0378-5955 75 1-2, 161-174.